
from
Independent International Investment Research3 page report
published Oct 22, 2009
Price
$15.00 available for immediate download
Report Overview
Search Inside
About
Independent International Inve...
Novartis AG (Novartis) reported marginal growth in total revenues in 3Q 09, marginally exceeding our expectations. EBITDA margin was in line, while net margin fell short of our expectations...
|
| Source: | IIR Group PLC
|
| Document ID: | GER25515SN
|
| Country: | Switzerland
|
| Industry: | Pharmaceutical
|
| Ticker: | NOVN=CH
|
| Primary ISIN: | US66987V1098
|
| Primary Sedol: | 2620105
|
| Free Sample: |
Click Here to Download
|
| Format: | | PDF |  |
|
Independent International Investment Research is the UK's leading source of truly impartial research and strategy for global equities and currencies.